Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company specializing in advanced software solutions for radiation therapy and oncology. Founded in 2000 as a spin-off from the Karolinska Institute in Stockholm, it develops innovative tools to enhance cancer treatment precision and efficiency. Its flagship products include the RayStation treatment planning system, which optimizes radiation delivery; RayCare, an oncology information system for comprehensive patient management; RayIntelligence, an oncology analytics platform that collects, structures, and analyzes clinical data; and RayCommand, a treatment control system integrating machines with planning and information systems. These solutions support over 2,600 clinics across more than 40 countries, empowering healthcare providers worldwide in the fight against cancer through cutting-edge innovation and collaboration with leading centers. The company maintains a dual-class share structure, with Class B shares listed since 2003, reflecting its established presence in the medical technology sector. RaySearch Laboratories AB (publ) plays a pivotal role in driving software-led advancements in radiation oncology, transforming data into actionable insights for improved patient outcomes.